MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Net Income
-$5,294,448
EPS
-$0.16
Unit: Dollar
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
General and administrative
2,027,664
1,934,324
7,754,447.5*
1,752,262
Research and development
3,685,618
2,942,320
2,721,416.5*
1,357,793
Loss from operations
-5,713,282
-4,876,644
-10,475,864*
-3,110,055
Change in fair value of warrant liabilities
-20,624
-1,542,132
-57,650*
-46,870
Realized foreign currency translation loss from dissolution of subsidiaries
-
-
-1,792.75*
-
Foreign currency (loss) gain
-29,792
-9,491
109,126*
-26,250
Other income
38,182
24,183
-62,745*
8,619
Change in fair value of derivative warrant liability
-
-
104,154.75*
-
Interest and dividends, net
410,416
450,338
180,463*
43,396
Other income, net
439,430
2,007,162
178,546.5*
72,635
Loss before income taxes
-5,273,852
-2,869,482
-10,297,317.5
-3,037,420
Net loss
-5,273,852
-2,869,482
-10,297,317.5*
-3,037,420
Foreign currency translation
-20,596
28,132
-17,132*
18,301
Comprehensive loss
-5,294,448
-2,841,350
-10,314,449.5
-3,019,119
Basic EPS
-0.16
-0.12
-1.288
-0.41
Diluted EPS
-0.16
-0.12
-1.288
-0.41
Basic Average Shares
32,100,063
24,337,812
8,008,322
7,443,577
Diluted Average Shares
32,100,063
24,337,812
8,008,322
7,443,577
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Comprehensive loss-$5,294,448 (-42.69%↓ Y/Y)Net loss-$5,273,852 (-41.92%↓ Y/Y)Foreign currencytranslation-$20,596 (-465.76%↓ Y/Y)Interest and dividends,net$410,416 (654.11%↑ Y/Y)Other income$38,182 (96.17%↑ Y/Y)Change in fair value ofwarrant liabilities-$20,624 (-344.48%↓ Y/Y)Loss before incometaxes-$5,273,852 (-41.92%↓ Y/Y)Other income, net$439,430 (363.82%↑ Y/Y)Foreign currency (loss)gain-$29,792 Loss from operations-$5,713,282 (-49.92%↓ Y/Y)Research and development$3,685,618 (71.53%↑ Y/Y)General andadministrative$2,027,664 (21.99%↑ Y/Y)

Pasithea Therapeutics Corp. (KTTAW)

Pasithea Therapeutics Corp. (KTTAW)